Novel Biomarker Boosts Diagnostic Accuracy of Nasopharyngeal Cancer Screening
(MedPage Today) -- A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed.
Screening with P85-Ab, an anti-BNLF2b total antibody...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | China Health | Hematology | Nasopharyngeal Cancer | Study